Kozak & Associates’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11
Closed -$3.11K 420
2026
Q1
$3.08K Hold
11
﹤0.01% 349
2025
Q4
$3.1K Hold
11
﹤0.01% 345
2025
Q3
$3K Buy
+11
New +$3.25K ﹤0.01% 357
2023
Q4
Hold
0
363
2023
Q3
Sell
-3
Closed -$856 380
2023
Q2
$878 Hold
3
﹤0.01% 336
2023
Q1
$797 Hold
3
﹤0.01% 326
2022
Q4
$1K Hold
3
﹤0.01% 317
2022
Q3
$1K Hold
3
﹤0.01% 311
2022
Q2
$1K Hold
3
﹤0.01% 351
2022
Q1
$1K Hold
3
﹤0.01% 361
2021
Q4
$1K Hold
3
﹤0.01% 361
2021
Q3
$1K Buy
+3
New +$652 ﹤0.01% 314

Other funds holding CI

Kozak & Associates's CI Position: Q2 2026 in Review

Kozak & Associates sold out of Cigna (CI) in Q2 2026, closing a stake of 11 shares — an estimated $3.11K sold.

Kozak & Associates first reported a position in CI in Q3 2021 and held it in 11 quarters. The position peaked at $3.1K in Q4 2025. 476 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Kozak & Associates reported no remaining Cigna position as of Q2 2026 after selling out during the quarter.
  • Kozak & Associates sold 11 Cigna shares in Q2 2026, an estimated $3.11K.
  • Kozak & Associates first reported a position in Cigna in Q3 2021 and held it in 11 quarters.
  • Kozak & Associates's Cigna position peaked at $3.1K in Q4 2025.
  • 476 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.